Skip to main content
العنوان الوكيل الحالة الدواء المرحلة رقم البروتوكول موقع الدراسة
A Prospective Phase II study utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients with Advanced Colorectal Cancer KAIMRC Ongoing PANITUMUMAB - cetuximab 2 RC20/170/R King Abdulaziz Medical City NG (Riyadh)
Deferoxamine management protocol in COVID-19 patients King Saud Medical City Ongoing Deferoxamine 2 20082103 King Saud Medical City (Riyadh)
A global multicenter,randomized,double-blind,placebo -controlled, adaptive designed phase Ⅲ clinical trial to evaluate the efficacy, safety and immunogenicity of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in adults 18 years old and above MOH / CanSino Rejected Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 3 CS-CTP-AD5NCOV-ⅢCo King Fahad Medical City (Riyadh)
A phase III randomized clinical trial comparing post-transplant cyclophosphamide with calcineurin inhibitors as a GVHD prophylaxis to standard care of methotrexate and calcineurin inhibitors for acute leukemia incorporating patient pharmacogenomic profiling – a personalized medicine approach in allogeneic hematopoietic cell transplantation PMAT King Faisal Specialist Hospital and Research Centre Ongoing CYCLOPHOSPHAMIDE (ENDOXAN) 3 1- 28/05/2019 KFSH & RC-R
Phase 2, Multi-Center, Double-Blind, Randomized, 2-Arm, Parallel Study to Assess the Efficacy and Safety of Ryanodex (EGL-4104) as Adjuvant Treatment in Subjects with Exertional Heat Stroke (EHS) Eagle Pharmaceuticals Ongoing Dantrolene 2 EGL-4104-C-1801 Mina Al-Shari' Al-Jadid Hospital
An Open-label, Baseline-controlled, Multicenter, Phase 3 Dose-titration Study Followed by a Fixed-dose Observation Period to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Children and Adolescents from 5 to less than 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC) Astellas Rejected Mirabegron 3 178-CL-206A King Abdulaziz University Hospital (Jeddah)
Vitamin D Status Correction and Validation of its Potential Clinical Utility through Discovery Proteomic Analysis Prince Mutaib Chair for Biomarkers of Osteoporosis/synergypha-rma Completed cholecalciferol 3 E-15-1667 KKUH
Vitamin D status and Covid-19 in Saudi Settings: A randomized open-label study on the possible role of vitamin D on improving clinical outcomes KKUH Ongoing VITA-D 3 H-01-R-012 King Fahad Medical City (Riyadh)
Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers Qassim University Ongoing Vitamin C (ascorbic acid ) Cevital 3 20111803 Mental Health Hospital (Abha)
V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy MSD Completed V212 3 V212-011 KFSH
عرض 1 - 10 من 604